NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » News » AngioDynamics’ DIRECT clinical study receives IRB approval for treating stage III pancreatic cancer » MDPR1

AngioDynamics’ DIRECT clinical study receives IRB approval for treating stage III pancreatic cancer

Image: AngioDynamics’ DIRECT clinical study receives IRB approval for treating stage III pancreatic cancer. Photo: Courtesy of rajcreationzs/FreeDigitalPhotos.net

NS Medical Devices is using cookies

Image: AngioDynamics’ DIRECT clinical study receives IRB approval for treating stage III pancreatic cancer. Photo: Courtesy of rajcreationzs/FreeDigitalPhotos.net

Related Article

What is a pulse oximeter and how is the device being used to combat Covid-19?

RECOMMENDED COMPANIES

MOST READ

European researchers are developing a new scanner to speed up detection of eye disease

What is a pulse oximeter and how is the device being used to combat Covid-19?

Q doctor poised to become biggest UK booking provider for Covid-19 vaccinations

Five of our favourite medical innovations from COMPAMED and MEDICA 2020

Six medical devices that help patients manage diabetes

Recommended Whitepaper